Susan Romanus
Plus aucun poste en cours
Fortune : 196 971 $ au 31/05/2024
Historique de carrière de Susan Romanus
Anciens postes connus de Susan Romanus
Sociétés | Poste | Début | Fin |
---|---|---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Compliance Officer | 01/01/2015 | 01/01/2018 |
DAIICHI SANKYO CO., LTD. | Compliance Officer | 01/01/2009 | 01/01/2012 |
Merck Vaccine Division | Compliance Officer | - | - |
ADC THERAPEUTICS SA | Compliance Officer | 01/08/2018 | - |
Formation de Susan Romanus
University of California San Diego | Undergraduate Degree |
University of San Diego | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 5 |
Suisse | 2 |
Japon | 2 |
Opérationnelle
Compliance Officer | 4 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
DAIICHI SANKYO CO., LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Merck Vaccine Division |
- Bourse
- Insiders
- Susan Romanus
- Expérience